Login / Signup

No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients.

Lasse Bach SteffensenSøren FeddersenSimone Rørdam PreilLars Melholt Rasmussen
Published in: Cardiovascular diabetology (2018)
Our data suggest that alternatives to microRNA dysregulation underlie T2DM-associated protein changes in non-atherosclerotic arteries.
Keyphrases
  • poor prognosis
  • type diabetes
  • electronic health record
  • blood flow
  • binding protein
  • data analysis